Abstract: The invention relates to an electric machine (24) comprising at least one disc-shaped rotor (58, 60) received on a shaft (52). The at least one disc-shaped rotor (58, 60) is provided with a brake disc (54) of an eddy current brake (22) on one side. The invention also relates to the use of the electric machine (24) with at least one integrated eddy current brake (22) as a central brake on a front axle (12) and/or a rear axle (38) of an electrically operated vehicle (10).

Abstract: A method for detecting a malfunction of an electromechanical braking device of a braking system for a motor vehicle. The braking device has at least one controllable electric motor and at least one actuator element that can be displaced by the electric motor, wherein in the idle state of the braking device the actuator element has a clearance in the actuation direction. For a test procedure, the electric motor is controlled such that the actuator element is displaced only within the clearance, and the presence of a malfunction is ascertained according to at least one operating parameter of the electric motor detected in the process.

Abstract: An electromechanical drum brake for a motor vehicle. The electromechanical drum brake includes a drum, in which brake shoes are arranged, and an adjusting device, which is arranged between the brake shoes and driven by a drive unit and via which the brake shoes can be spread for braking. An end of each brake shoe that faces the adjusting device is supported on a support element cooperating with the adjusting device, movably in relation to the support element, wherein a spreading force of the adjusting device is transferable to the brake shoes via the support element.

Abstract: A single-piece component for a magnetic actuator, in particular for fuel injection, including an internal pole, a magnetic sleeve, and a non-magnetic separating sleeve, the internal pole, the magnetic sleeve and the separating sleeve being integrated into the single-piece component. A method for manufacturing a single-piece component for an magnetic actuator with the aid of a two-component powder injection molding method.

Abstract: A solenoid armature for a solenoid actuator, including at least one magnetic region and at least one non-magnetic region, the solenoid armature being configured as a one-piece component having a first and second armature end face, the magnetic and non-magnetic regions being integrally bonded to each other by a two-component powder injection molding technique, and the magnetic region and the non-magnetic region extending in the axial direction at least as far as the first armature end face.

Abstract: The present invention relates to compounds of general formula I wherein n, R1, R2, R3, R4, R5, R6, R7 and R8 are defined as stated hereinafter, the enantiomers, the diastereomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with organic or inorganic acids or bases, which have valuable properties, the preparation thereof, the pharmaceutical compositions containing the pharmacologically effective compounds, the preparation thereof and the use thereof.

Abstract: Disclosed are compounds of the formula I wherein A, Y, R1, R2, R3, R4 and R5 are defined, suitable for treating diseases and symptoms of diseases caused at least to some extent by stimulation of bradykinin-B1 receptors, the preparation thereof and the use thereof.

Abstract: A single-piece component for a magnetic actuator, in particular for fuel injection, including an internal pole, a magnetic sleeve, and a non-magnetic separating sleeve, the internal pole, the magnetic sleeve and the separating sleeve being integrated into the single-piece component. A method for manufacturing a single-piece component for an magnetic actuator with the aid of a two-component powder injection molding method.

Abstract: Novel compounds which are useful for treating acute pain, visceral pain, neuropathic pain, inflammatory/pain receptor-mediated pain, tumor pain and headache diseases.

Abstract: The present invention relates to the compounds of general formula I wherein n, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and X are defined as described hereinafter, the enantiomers, the diastereomers, the mixtures and the salts thereof, particularly the physiologically acceptable salts thereof with organic or inorganic acids or bases, which have valuable properties, the preparation thereof, the medicaments containing the pharmacologically effective compounds, the preparation thereof and the use thereof.

Abstract: Novel compounds of which the following is exemplary:

Abstract: A solenoid armature for a solenoid actuator, including at least one magnetic region and at least one non-magnetic region, the solenoid armature being configured as a one-piece component having a first and second armature end face, the magnetic and non-magnetic regions being integrally bonded to each other by a two-component powder injection molding technique, and the magnetic region and the non-magnetic region extending in the axial direction at least as far as the first armature end face.

Abstract: Compounds of the formula I wherein n, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and X are defined as described in the specification, which are bradykinin B1 antagonists, and their use as medicaments.

Abstract: In a valve for controlling a fluid passage, a valve needle is actuated by a first electromagnetic drive having a first armature element and is reset by a return element, and a second electromagnetic drive is provided having a second armature element for actuating the valve needle. The first and second electromagnetic drive are configured in series.

Abstract: The present invention relates to compounds of general formula I wherein A, B, D, Y, R1, R2, R3, R4 and R5 are defined as in the specification, the enantiomers, the diastereomers, the mixtures and the salts thereof, particularly the physiologically acceptable salts thereof with organic or inorganic acids or bases, which have valuable properties, the preparation thereof, the pharmaceutical compositions containing the pharmacologically effective compounds, the preparation thereof and the use thereof.

Abstract: Compounds of the formula I wherein n, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and X are defined as described in the specification, which are bradykinin B1 antagonists, and their use as medicaments.

Abstract: Compounds of formula 1 and hetero derivatives thereof and the pharmacologically acceptable salts, enantiomers, racemates, hydrates, or solvates thereof, which are suitable for the treatment of respiratory or gastrointestinal complaints or diseases, inflammatory diseases of the joints, skin, or eyes, diseases of the peripheral or central nervous system or cancers, as well as pharmaceutical compositions which contain these compounds.

Abstract: Novel compounds which are useful for treating acute pain, visceral pain, neuropathic pain, inflammatory/pain receptor-mediated pain, tumour pain and headache diseases.

Abstract: The present invention relates to compounds of general formula I wherein n, R1, R2, R3, R4, R5, R6, R7 and R8 are defined as stated hereinafter, the enantiomers, the diastereomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with organic or inorganic acids or bases, which have valuable properties, the preparation thereof, the pharmaceutical compositions containing the pharmacologically effective compounds, the preparation thereof and the use thereof.

Abstract: The invention relates to a method of treating immunologic diseases or pathological conditions involving an immunologic component using certain Lck inhibitors already known as kinase inhibitors for therapy in oncology, optionally in combination with one or more other drugs selected from NSAIDs, steroids, DMARDs, immunsuppressives, biologic response modifiers and antinfectives, pharmaceutical compositions comprising said Lck inhibitors together with said other drugs, and the use of the Lck inhibitors for the manufacture of a pharmaceutical composition for the treatment of immunologic diseases or pathological conditions involving an immunologic component.